MTOR and cancer: Nevertheless, the literature, at least, clearly highlights that miRNAs can foster or inhibit cancer properties according to their ability to target oncogenes, as well as oncosuppressors (EGFR, mTOR, VHL, HIF-1α, PDGFβ, TP53, PTEN, BAP1, SETD2, PBRM1, KDM5C) [112].